Dovonex (calcipotriol) / LEO Pharma, Novartis 
Welcome,         Profile    Billing    Logout  
 10 Diseases   7 Trials   7 Trials   309 News 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dovonex (calcipotriol) / LEO Pharma, Novartis
2005-000707-34: The induction of apoptosis by anti-psoriatic treatments

Ongoing
4
100
Europe
INFLIXIMAB, ETANERCEPT, METHOTREXATE SODIUM TABLETS, CICLOSPORIN A CAPSULES, HYDROXYCARBAMIDE, ACITRETIN, CALCIPOTRIOL, HYDROMOL, SHORT CONTACT DITHRANOL IN HYDROMOL, DITHRANOL IN LASSAR'S PASTE, STRONG COAL TAR SOLUTION IN HYDROMOL, PUVASORALEN-8, Powder for injection*, Powder and solvent for solution for injection, Tablet, Capsule*, Cream, Ointment, REMICADE, ENBREL, METHOTREXATE, NEORAL, HYDREA, NEOTIGASON, DOVONEX CREAM, DOVONEX OINTMENT, HYDROMOL OINTMENT, METHOXSALEN
The Newcastle upon Tyne Hospitals NHS Trust
Psoriasis
 
 
2013-000778-31: Vitamin D and Psoriasis Vitamina D e Psoriasi

Ongoing
4
40
Europe
DAIVONEX, Cream, DAIVONEX
CLINICA DERMATOLOGICA POLICLINICO UMBERTO I "SAPIENZA", Associazione Romana Ricerca Dermatologica
Psoriatic skin Cute psoriasica, Psoriasis Psoriasi, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
2005-000546-37: An investigation of the effect of Vitamin D Receptor genotypes on clinical response to treatment of psoriasis with a topical vitamin D analogue and molecular mechanisms

Ongoing
4
30
Europe
Dovonex ointment, Dovonex ointment, Dovonex ointment
University Hospitals of Leicester NHS Trust
Psoriasis - an inflammatory skin disease with a genetic basis
 
 
2007-005672-13: DOUBLE-BLIND STUDY, RANDOMISED, ACTIVE AND PLACEBO CONTROLLED TO ASSESS THE CLINICAL EFFICACY, SKIN TOLERABILITY AND PHARMACOLOGICAL ACTIVITY OF UR-1505 OINTMENT AT THREE DIFFERENT STRENGHTS IN PATIENTS WITH MILD TO MODERATE PLAQUE-TYPE PSORIASIS

Ongoing
2
60
Europe
UR-1505 0.5% OINTMENT, UR-1505 2% OINTMENT, UR-1505 4% OINTMENT, UR 1505, DAIVONEX, DAIVONEX
PALAU PHARMA SA
Patients suffering from psoriasis with at least two eligible psoriatic plaques on equivalent topographic areas (arms, legs or trunk)
 
 
2007-005463-10: A plaque test comparing three marketed products and two products in development and a vehicle control for the treatment of psoriasis vulgaris

Ongoing
2
24
Europe
Calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g, Calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g, LEO 80185 gel, LEO 80190 ointment, Daivobet® ointment, Daivonex® cream, Daivonex® ointment, Daivobet® ointment, Daivonex® cream, Daivonex® ointment
LEO Pharma A/S
Psoriasis vulgaris lesions located on the arms, legs or trunk.
 
 
2015-003893-34: STUDY OF THE EFFICACY AND SAFETY OF A PAD™ CALCIPOTRIOL CREAM IN THE PSORIASIS PLAQUE TEST ETUDE DE L’EFFICACITE ET DE LA TOLERANCE DU PAD™ CALCIPOTRIOL CREME DANS LE TEST DE LA PLAQUE PSORIASIQUE

Not yet recruiting
2
24
Europe
PAD™ calcipotriol cream, PAD™ combination cream, DAIVOBET, DAIVONEX, CALCIPOTRIOL SANDOZ, MC2-01 (calcipotriol), MC2-01 (calcipotriol/betamethasone dipropionate), Cream, Ointment, DAIVOBET, DAIVONEX, CALCIPOTRIOL SANDOZ
Drug Delivery Solutions Aps (DDS) c/o MC2 Biotek Group, Drug Delivery Solutions Aps (DDS) c/o MC2 Biotek Group
Psoriasis vulgaris, Psoriasis, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
2019-000175-16: A Study to Evaluate AVX001 in Psoriasis Patients

Not yet recruiting
2
15
Europe
AVX001 0.75%, AVX001 1.5%, AVX001 3%, Ointment, Daivonex® 50 µg/g, Diprosone 0,64 mg/g
Avexxin AS, Avexxin AS
Chronic psoriasis vulgaris, Psoriasis, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
2019-001189-14: A study to explore the safety and efficacy of bimiralisib applied to the skin in patients with an inflammatory skin condition

Not yet recruiting
2
36
Europe
Topical bimiralisib gel, Daivobet, Daivonex, PQR309, Gel, Ointment, Daivobet, Daivonex
PIQUR Therapeutics AG, PIQUR Therapeutics AG
inflammatory and hyperproliferative skin condition, inflammatory skin condition, Diseases [C] - Immune System Diseases [C20]
 
 
NCT05699603: Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients

Recruiting
2
56
US
Biopsy, BIOPSY_TYPE, Bx, Calcipotriene, Calcipotriol, Dovonex, Fluorouracil, 5 Fluorouracil, 5 Fluorouracilum, 5 FU, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-Fu, 5FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757
University of Arizona, National Cancer Institute (NCI)
Actinic Keratosis
02/27
02/29
2005-005897-54: A Phase 1, Single-Centre, Single-blind, CPO Solution Human Patch Test in Healthy Subjects

Ongoing
1
26
Europe
CPO 1.5% Leave-on Solution, CPO 1.0% Solution, CPO 0.5% Solution, Mycoster 1%, Batrafen Solution, Dovonex Scalp Solution, Not Applicable, Mycoster 1%, Batrafen Solution, Dovonex Scalp Solution, Mycoster 1%, Batrafen Solution, Dovonex Scalp Solution
Stiefel Laboratories Maidenhead Ltd
Not Applicable (Healthy Volunteer Study)
 
 
CCCA, NCT05416320: Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Withdrawn
1
10
US
Calcipotriol, Dovonex, Subject's already prescribed drug
Wake Forest University Health Sciences
Central Centrifugal Cicatricial Alopecia
11/23
12/23
NCT04275024: Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients

Completed
N/A
8
RoW
Calcipotriol ointment, Dovonex, PSORI-CM01 Granule, Chinese Herbal Medicine, adipose-derived multipotent mesenchymal stem cells
Guangdong Provincial Hospital of Traditional Chinese Medicine
Mesenchymal Stromal Cells, Psoriasis, Drug Effect, Drug Toxicity
06/20
02/21

Download Options